AEterna Zentaris Inc (AEZS.OQ)

AEZS.OQ on NASDAQ Stock Exchange Capital Market

1:17pm EDT
Price Change (% chg)

$-0.01 (-0.85%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AEZS.OQ


Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in... (more)


Beta: 1.83
Market Cap (Mil.): $66.73
Shares Outstanding (Mil.): 56.51
Dividend: --
Yield (%): --


  AEZS.OQ Industry Sector
P/E (TTM): -- 26.72 33.26
EPS (TTM): -0.78 -- --
ROI: -52.43 -2.48 18.95
ROE: -525.41 -11.48 19.72
Search Stocks

BRIEF-AEterna Zentaris U.S.-listed shares down 21.2 percent premarket

NEW YORK, Jan 9 - AEterna Zentaris Inc : * U.S.-listed shares down 21.2 percent to $1.15 in premarket; prices $13.2 million public offering of common shares and warrants

09 Jan 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks